Bryan Roberts, Ph.D. Partner Office: Palo Alto Email Bryan Education B.A., Chemistry, Dartmouth College, Phi Beta Kappa Ph.D., Chemistry & Chemical Biology, Harvard University

Bryan joined Venrock as a Kauffman Fellow in 1997. Previously, he earned his Ph.D. in Chemistry & Chemical Biology at Harvard University and, prior to his doctoral program, held corporate finance positions at Kidder, Peabody and Co.  Bryan was named a Henry Crown Fellow by the Aspen Institute in 2006, he was named to healthspottr’s 2009 Future Health 100 list and was the highest-ranking healthcare investor on Forbes’ Midas List in 2008 and 2009.  

“We do everything in our power to be company builders rather than simply investors, creating true partnerships with entrepreneurs. If you always put the company’s interests first, working to create truly substantial and sustainable market leading enterprises, everything else generally takes care of itself. You can create new products, improve people lives and generate tremendous shareholder value.”

 “What has been really valuable for XenoPort is Bryan Roberts' intense company-centric focus.  He has always put XenoPort's interests first and is dedicated to building a large, sustainable enterprise.  Bryan had drawn upon Venrock's extensive history of success in biotech and their wide range of resources to further our success, including business development, financing, and recruiting.  It has all worked together very effectively."
Ron Barrett, Founder and CEO, XenoPort

“Bryan Roberts is a partner in the truest sense of the word. He is one of the smartest, most dedicated people I have ever worked with and his counsel has been invaluable. He brings a superhuman capacity for work and a willingness to help surmount any problem at every stage of a company’s development. Bryan always puts the company first, working to create an important and enduring business.”
Peter Hecht, CEO, Ironwood Pharmaceuticals